ArticleBMC geriatrics2025
Nomogram for severe low-voltage areas prediction in older patients with paroxysmal atrial fibrillation: a retrospective cohort study.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundLow-voltage areas (LVA) are recognized as substrate for atrial fibrillation (AF) recurrence following pulmonary vein isolation. This study aimed to develop a nomogram for predicting the probability of severe LVA (≥ 10% ) in older patients with paroxysmal AF.
methodsThe older patients aged 65–80 years with paroxysmal AF were retrospectively analyzed from January 2018 - June 2021 and April 2022 - March 2024. Patients were divided into a training cohort and an external validation cohort based on enrollment period. By integrating the least absolute shrinkage and selection operator (LASSO) and multivariable logistic regression analysis, crucial variables were determined for establishment of the nomogram. Model performance was assessed by bootstrap validation, receiver operating characteristic (ROC) curve analysis, calibration curves, and decision curve analysis (DCA). Meanwhile, the external validation cohort was conducted to evaluate the model’s generalizability.
resultsThis study enrolled 873 patients, and 60 patients suffered from severe LVA. Sex, age and left atrial diameter emerged as independent predictors and were incorporated into the nomogram. The mean optimism-corrected C-index of Bootstrap validation was 0.765 (95% CI: 0.6782–0.8519). The area under the ROC curve was found to be 0.782 (95% CI: 0.718–0.845) in the training cohort (694) and 0.774 (95% CI: 0.623–0.924) in the validation cohort (179). Additionally, the calibration curves displayed a favorable agreement between predicted and observed outcomes, and DCA indicated clinical benefit when the threshold probability ranged from 11% to 83% (training) and from 15% to 72% (validation).
conclusionThis is the first study to establish and externally validate a nomogram for the prediction of severe LVA in older patients with paroxysmal AF. This model may facilitate accurate risk stratification, guide individualized procedural planning, and inform optimal strategies for substrate modification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.